07/14/2023 Edition 99
----- Division of Research -----
|
|
2023 Sony Research Award Program |
|
2023 Sony Research Award Program. Up to $100,000 in funds to conduct cutting-edge research in Sony's general areas of interest or up to $150,000 in funds to conduct research in the areas of Sony's immediate interest. Proposal deadline: September 15, 2023.
Learn more about the Sony Research Award Program, submission guidelines, and application deadlines during Sony’s webinar with Mark Ortiz, senior manager of the Strategy & Planning Office for Sony Corporation of America’s R&D Center U.S. Laboratory.
The Sony Research Award Program is an academic award initiative created to provide U.S., Canadian, select European countries, and Indian universities funding for emerging and innovative technology research projects in collaboration with Sony’s own research division. The program comprises the Faculty Innovation Award and the Focused Research Award within three broad subject categories: Information Technology, Devices & Materials, and Life Sciences. The Program is now in its eighth year.
With awards of up to $150,000 per year for each accepted proposal, the Sony Research Award Program creates new opportunities for university faculty to engage in pioneering research that could drive new technologies, industries, and the future.
|
|
NIH Validation for Alzheimer's Disease |
|
The purpose of the NOFO is to support the comprehensive and rigorous validation of two or more novel interacting disease modifying therapeutic targets for Alzheimer’s Disease-Related Dementias (ADRD). This is with the goal of supporting future development of therapies reflecting the complexity of human dementia. Target validation includes experiments performed with the goal of increasing confidence that the proposed pathways, circuits, systems, etc. are causal of the disease state and that perturbing the targets could positively impact patients while maintaining safety. This NOFO supports validation of multiple targets as ADRDs can involve multiple pathways and pathologies and targeting more than one could be synergistic. Such synergistic targets would be impactful for a subset of patients based on pathology or underlying mechanism.
|
|
NIH Grants for Aging Research |
|
The goal of the Grants for Early Medical/Surgical Specialists' Transition to Aging Research (GEMSSTAR) program is to provide support for early-career physician-scientists trained in medical or surgical specialties and early-career dentist-scientists to launch careers as future leaders in aging- or geriatric-focused research. In support of the program's goal, this GEMSSTAR notice of funding opportunity (NOFO) invites applications that propose to conduct transdisciplinary aging research that will yield pilot data and experience for subsequent aging research projects. The GEMSSTAR program encourages candidates to seek out a supportive research environment to achieve the program's goal of fostering the development of early-career physician- and dentist-scientists in aging- or geriatric-focused research, particularly as it applies to their clinical specialty/discipline. In selecting GEMSSTAR awardees, the National Institute on Aging (NIA) will consider the extent to which a candidate's environment is supportive of aging- or geriatric-focused research.
|
|
Specific Area of Interest: Through this RFP it is our intent to support educational programs that address potential knowledge gaps related to drug-drug interactions (DDIs) in COVID-19 outpatient treatment and are designed to help achieve the following goals:
- Improve ability to assess patients for potential DDIs prior to treatment
- Increase confidence with managing DDIs (monitoring parameters, dose adjustments, therapy adjustments, etc.) and potential adverse events
- Increase awareness of tools available to manage DDIs for outpatient COVID-19 therapeutics
- Increase awareness of national COVID-19 treatment guidelines (e.g., NIH, IDSA, etc.) for COVID 19 in non-hospitalized patients.
|
|
Specific Area of Interest: Projects that will be considered for support will focus on addressing patient education on disease awareness, diagnosis, treatment, adherence, and general management of patients living with migraine.
|
|
Althea Sheets, Research, Scholarly, and Creative Activities Development Manager, Office of Sponsored Programs, [email protected], 702-895-1880
|
|
|
|
|
|
|
|
